PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+13.34%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$14.1M
AUM Growth
+$14.1M
(-77%)
Cap. Flow
-$49.5M
Cap. Flow
% of AUM
-351.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Fate Therapeutics
FATE
|
$49.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Lyra Therapeutics
LYRA
$11.5M
| $10M | 71.28% |
1,100,852
| – | – |
|
2
X4 Pharmaceuticals
XFOR
$84.2M
| $1.65M | 11.7% |
311,492
| – | – |
|
|
ATYR
3
aTyr Pharma
ATYR
$527M
| $1.19M | 8.42% |
130,572
| – | – |
|
4
Dare Bioscience
DARE
$27.2M
| $545K | 3.87% |
326,240
| – | – |
|
|
GNCA
5
DELISTED
Genocea Biosciences, Inc.
GNCA
| $379K | 2.69% |
197,345
| – | – |
|
6
Pulmatrix
PULM
$18M
| $288K | 2.04% |
359,441
| – | – |
|
|
7
Fate Therapeutics
FATE
$120M
| – | – |
-569,889
| Closed | -$49.5M |
|